Continuity of Care for Patients with Chronic Lymphocytic Leukemia: An Analysis of Real-World Data

被引:0
|
作者
Gaballa, Sameh [1 ]
Khanal, Manoj [2 ]
Chen, Yongmei [2 ]
Bhandari, Naleen Raj [2 ]
Winfree, Katherine B. [2 ]
Abhyankar, Sarang [2 ]
Hess, Lisa M. [2 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Eli Lilly & Co, Indianapolis, IN USA
关键词
D O I
10.1182/blood-2024-203246
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:5033 / 5034
页数:2
相关论文
共 50 条
  • [31] Real-world treatment patterns and health care resource utilization (HRU) among patients with chronic lymphocytic leukemia (CLL) by regimen
    Schenkel, Brad
    Ellis, Lorie
    Korrer, Stephanie
    Byfield, Stacey DaCosta
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [32] Real-World Treatment of Patients with Chronic Lymphocytic Leukemia: Results from Analysis of US Health Insurance Claims Dataset
    Liu, Yangyang
    Attinson, Dionna
    Chen, Quan
    Askin, Gulce
    Sajedian, Renee
    Choi, Julia
    Manzoor, Beenish
    McNeill, Annie
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 178 - 179
  • [33] Real-World Treatment Patterns and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib in the UK: A Preliminary Analysis
    Xie, Jing
    Yong, Alan
    Waweru, Catherine
    Sorof, Thuy Anh
    Goyal, Ravi K.
    Davis, Keith L.
    Follows, George
    Hillmen, Peter
    BLOOD, 2019, 134
  • [34] Real-World Evaluation of Treatment Discontinuation and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    Chanan-Khan, Asher Alban
    Challagulla, Swetha
    Donckels, Elizabeth
    Chuang, Po-Ya
    Yang, Keri
    BLOOD, 2023, 142
  • [35] Real-world ibrutinib dose reductions, holds and discontinuations in chronic lymphocytic leukemia
    Hou, Jing-Zhou
    Ryan, Kellie
    Du, Senxi
    Fang, Bruno
    Marks, Stanley
    Page, Ray
    Peng, Eileen
    Szymanski, Keith
    Winters, Sharon
    Le, Hannah
    FUTURE ONCOLOGY, 2021, 17 (35) : 4959 - 4969
  • [36] Chronic Lymphocytic Leukemia (CLL) real world data form UnitedArabEmirates
    Alam, Arif
    Alam, Nida
    McCarthy, Phillip
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S53 - S53
  • [37] REAL-WORLD EXPERIENCE OF IBRUTINIB IN >2900 CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: DATA FROM A GLOBAL NAMED PATIENT PROGRAM
    Hillmen, P.
    Diels, J.
    Healy, N.
    Iraqi, W.
    Aschan, J.
    Wildgust, M.
    HAEMATOLOGICA, 2016, 101 : 51 - 51
  • [38] Impact of ibrutinib on quality of life in patients with chronic lymphocytic leukemia: preliminary results of real-world experience
    Osorio, Maria J. Mela
    Pavlovsky, Astrid
    Pavlovsky, Carolina
    Fernandez, Isolda
    Massa, Federico Sackmann
    Ferrari, Luciana
    Juni, Mariana
    Riddick, Maximiliano
    Pavlosky, Miguel
    LEUKEMIA & LYMPHOMA, 2020, 61 : 195 - 197
  • [39] Real-World Effectiveness of Frontline Treatments Among Patients with Chronic Lymphocytic Leukemia: Results from ConcertAI
    Roeker, Lindsey E.
    Burke, John M.
    Rhodes, Joanna M.
    Emechebe, Nnadozie
    Jawaid, Dureshahwar
    Manzoor, Beenish S.
    Jensen, Christopher E.
    Ryland, Lindsay
    Liu, Yangyang
    Marx, Steve E.
    Sinai, Wendy
    Roser, Jordan
    Shadman, Mazyar
    CANCERS, 2025, 17 (05)
  • [40] REAL-WORLD OUTCOMES OF PATIENTS WITH RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA WITH 17P DELETION
    Lamanna, N.
    Hurst, D.
    Latremouille-Viau, D.
    Ionescu-Ittu, R.
    Guerin, A.
    Yim, Y. M.
    Reyes, C.
    HAEMATOLOGICA, 2015, 100 : 421 - 422